InsiderFlow

Patrick D Yeramian

AMLX

Patrick D Yeramian serves as Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$3.72M

Net Position

Net Seller

$3.72M

Companies Traded

1

AMLX

Active Period

Jan 2023 – Jan 2024

5 total trades

Most Recent

Sell AMLX

Jan 9, 2024 · $45.9K

Patrick D Yeramian's Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

0 · $0.00

Sells

5 · $3.72M

Total Shares Bought

0

Total Shares Sold

121,017

AMLX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jan 9, 2024Sell2,812$16.33$45.9K0
May 15, 2023Sell11,965$29.03$347.4K0
Apr 17, 2023Sell49,579$30.54$1.51M0
Mar 16, 2023Sell54,627$31.87$1.74M0
Jan 6, 2023Sell2,034$36.30$73.8K0